West Pharmaceutical Services WST Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $493.7M+0.2% | $492.7M-17.0% | $593.4M+1.3% | $585.9M-11.5% | ||
| $168.6M+11.1% | $151.8M+13.5% | $133.7M+14.4% | $116.9M0.0% | ||
| $23.8M+27.3% | $18.7M-19.7% | $23.3M-1.7% | $23.7M-36.8% | ||
| $11.7M+60.3% | $7.3M-24.0% | $9.6M+54.8% | $6.2M+10.7% | ||
| -$6.9M-112% | $58.8M+1,570% | -$4M-111% | $35.6M-71.2% | ||
| $62.8M+250% | -$42M-411% | $13.5M-72.9% | $49.8M-42.4% | ||
| $17.9M+517% | $2.9M-34.1% | $4.4M+257% | -$2.8M-117% | ||
| -$108.1M-378% | -$22.6M-277% | -$6M+89.0% | -$54.7M-2,179% | ||
| -$9.7M-267% | $5.8M-72.8% | $21.3M+215% | -$18.5M-353% | ||
| $10.5M-21.6% | $13.4M-6.3% | $14.3M-21.0% | $18.1M+4.0% | ||
| $754.8M+15.5% | $653.4M-15.9% | $776.5M+7.3% | $724M+24.0% | ||
| $285.9M-24.2% | $377M+4.1% | $362M+27.2% | $284.6M+12.3% | ||
| -$285.9M+24.5% | -$378.7M-2.7% | -$368.7M-27.9% | -$288.2M-13.9% | ||
| $61.2M+3.6% | $59.1M+3.7% | $57M+5.4% | $54.1M+5.9% | ||
| —— | $560.9M+28.0% | $438.3M+116% | $202.9M— | ||
| $11.3M-55.7% | $25.5M-41.9% | $43.9M+110% | $20.9M-28.9% | ||
| $1.1M-95.3% | $23.4M+23,300% | $100K— | $0— | ||
| $2.8M-50.9% | $5.7M-55.8% | $12.9M-33.5% | $19.4M+31.1% | ||
| -$185.1M+70.3% | -$622.6M-35.5% | -$459.6M-56.5% | -$293.6M-74.3% | ||
| —— | -$21.4M-283% | $11.7M— | —— | ||
| $306.7M— | —— | -$40.4M— | —— | ||
| $300K-40.0% | $500K-91.7% | $6M-9.1% | $6.6M-17.5% | ||
| $125.2M+75.4% | $71.4M-21.4% | $90.8M-17.2% | $109.7M-36.1% | ||
| $2.8M-22.2% | $3.6M0.0% | $3.6M-2.7% | $3.7M-31.5% | ||
| $11.7M+60.3% | $7.3M-24.0% | $9.6M+54.8% | $6.2M+10.7% | ||
| $168.6M+11.1% | $151.8M+13.5% | $133.7M+14.4% | $116.9M0.0% | ||
| $10.5M-21.6% | $13.4M-6.3% | $14.3M-21.0% | $18.1M+4.0% | ||
| —— | —— | —— | —— | ||
| -$9.7M-267% | $5.8M-72.8% | $21.3M+215% | -$18.5M-353% | ||
| —— | —— | -$1M— | —— | ||
| $600K+130% | -$2M+23.1% | -$2.6M+81.4% | -$14M-195% | ||
| $1.1M-95.3% | $23.4M+23,300% | $100K— | $0— | ||
| $6.9M-4.2% | $7.2M+1.4% | $7.1M— | —— | ||
| —— | $0— | $0-100% | $15.3M— | ||
| $125.2M+75.4% | $71.4M-21.4% | $90.8M-17.2% | $109.7M-36.1% | ||
| $468.9M+69.6% | $276.4M-33.3% | $414.5M-5.7% | $439.4M+32.9% | ||
| $468.9M+69.6% | $276.4M-33.3% | $414.5M-5.7% | $439.4M+32.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does West Pharmaceutical Services generate?
- West Pharmaceutical Services (WST) generated $715.3M in operating cash flow over the trailing twelve months.
- What is West Pharmaceutical Services's free cash flow?
- After $257.3M of capital expenditures, West Pharmaceutical Services's free cash flow was $458.0M over the trailing twelve months, up 49.2% year over year.
- Where does West Pharmaceutical Services's cash flow data come from?
- Every line is extracted from West Pharmaceutical Services's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
